tetano
Editor, Senior Moderator
Hum Vaccin Immunother. 2017 Jun 12:0. doi: 10.1080/21645515.2017.1328332. [Epub ahead of print]
[h=1]Immunogenicity, safety and tolerability of intradermal influenza vaccines.[/h] Hung IFN[SUP]1,[/SUP][SUP]2[/SUP], Yuen KY[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Intradermal influenza vaccination has been studied for more than 80 years. The revived interest in this strategy of vaccination is a result of the innovative technologies in needle design allowing more precise injection and making the device easier to use. Furthermore, clinical trials on these novel devices have demonstrated significant dose sparing effects, improved immunogenicity and very few adverse effects. This review compares intradermal vaccination with various devices with subcutaneous and intramuscular vaccination. We also discussed the role of topical adjuvant before intradermal vaccination.
PMID: 28604266 DOI: 10.1080/21645515.2017.1328332
[h=1]Immunogenicity, safety and tolerability of intradermal influenza vaccines.[/h] Hung IFN[SUP]1,[/SUP][SUP]2[/SUP], Yuen KY[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Intradermal influenza vaccination has been studied for more than 80 years. The revived interest in this strategy of vaccination is a result of the innovative technologies in needle design allowing more precise injection and making the device easier to use. Furthermore, clinical trials on these novel devices have demonstrated significant dose sparing effects, improved immunogenicity and very few adverse effects. This review compares intradermal vaccination with various devices with subcutaneous and intramuscular vaccination. We also discussed the role of topical adjuvant before intradermal vaccination.
PMID: 28604266 DOI: 10.1080/21645515.2017.1328332